A one-two punch on clinical trials from Ruxandra Teslo and Willy Chertman today: first their on-point agenda for clinical trial abundance as a guest post in Slow Boring, then Ruxandra’s longer essay which has been so thoroughly research that even yours truly gets a name-check. As I noted elsewhere, every US institution has made one bade tradeoff after another in how it conducts clinical trials to the point that it’s impossible to conduct a RECOVERY trial equivalent over here. That needs to change.